Stephan Schlickeiser

Publications of

Stephan

Schlickeiser

  • A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies

    JCI Insight

  • CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells.

    Proc Natl Acad Sci U S A

  • Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16(+) Cell Subsets.

    Frontiers in Immunology

  • Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4(+) memory T cells.

    Nature Communications

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

    The Lancet

  • Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

    Cell

  • Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial.

    British Medical Journal

  • Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.

    American Journal of Transplantation

  • Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases.

    Nat Commun

Sawitzki Lab

Berlin Institute of Health at Charité (BIH) 
Center of Immunomics/Translational Immunology

Luisenstraße 65 
D-10117 Berlin

© 2026